Understanding how glyoxalase 1 affects obesity and diabetes
Glyoxalase 1 and its Role in Metabolic Syndrome
This study is looking at how a protein called GLO1 affects weight gain, blood sugar levels, and liver health in mice, which could help us find new ways to treat obesity, Type 2 diabetes, and fatty liver disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11049142 on NIH RePORTER |
What this research studies
This research investigates the role of glyoxalase 1 (GLO1) in the development of obesity, Type 2 diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD). By using advanced techniques like CRISPR-Cas9, researchers have created mice that lack GLO1 to observe how this affects their weight, glucose tolerance, and liver health when fed a high-fat, high-sugar diet. The study aims to uncover the mechanisms by which GLO1 influences metabolic processes and could lead to new treatment strategies for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are overweight or have been diagnosed with Type 2 diabetes or non-alcoholic fatty liver disease.
Not a fit: Patients who are not overweight or do not have metabolic syndrome-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that help manage or prevent obesity and Type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding metabolic pathways related to obesity and diabetes, suggesting that this approach could yield significant insights.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Galligan, James J — University of Arizona
- Study coordinator: Galligan, James J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.